RETRACTION: “Influence of Rosiglitazone on the Expression of PPAR γ , NF‐ κ B,and TNF‐ α in Rat Model of Ulcerative Colitis”
Gastroenterology Research and Practice · 2026-01 · 2026 (1)
DOI: 10.1155/grp/9859572 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gastroenterology Research and Practice, online erschienen am 08.06.2026. Verfasst von Gastroenterology Research And Practice. Die Arbeit nennt 2 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
[This retracts the article DOI: 10.1155/2012/845672.][This retracts the article DOI: 10.1155/2012/845672.].
Zitieren
APA
Research And Practice, G. (2026). RETRACTION: “Influence of Rosiglitazone on the Expression of PPAR γ , NF‐ κ B,and TNF‐ α in Rat Model of Ulcerative Colitis”. Gastroenterology Research and Practice, 2026(1). https://doi.org/10.1155/grp/9859572
Vancouver
Research And Practice G. RETRACTION: “Influence of Rosiglitazone on the Expression of PPAR γ , NF‐ κ B,and TNF‐ α in Rat Model of Ulcerative Colitis”. Gastroenterology Research and Practice. 2026;2026(1). doi:10.1155/grp/9859572
BibTeX
@article{ResearchAndPractice2026,
author = {Research And Practice, Gastroenterology},
title = {RETRACTION: “Influence of Rosiglitazone on the Expression of PPAR γ , NF‐ κ B,and TNF‐ α in Rat Model of Ulcerative Colitis”},
journal = {Gastroenterology Research and Practice},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/grp/9859572}
}
EUVIMED